•None of these events attributable to direct amide local anesthetic cardiac toxicity
•Thus, there is no substantive risk of cardiac toxicity from extravascular use of LB in this single institution study
•Butterworth, John F. Models and mechanisms of local anesthetic cardiac toxicity, a review. Regional Anesthesia and Pain Medicine, Vol. 35, No. 2, March-April 2010.
•Cox, B., Durieurx, M. E., and Marcus, M. A. E. Toxicity of local anesthetics. Best Practice & Research Clinical Anesthesiology. Vol. 17, No. 1. pp 111-136, 2003.
•Ilfeld, Brian M., et. al. Safety and side effect profile of Liposomal Bupivacaine (Exparel) in peripheral nerve blocks. Regional Anesthesia and Pain Medicine, Vol. 40, No. 5, September-October 2015.
•Richard, Brigitte M., et. al. Safety evaluation of EXPAREL (DepoFoam bupivacaine) administered by repeated subcutaneous injection in rabbits and dogs: species comparison. Journal of drug delivery, Vol. 2011.
•Viscusi, Eugene R., Sinatra, Raymond, Onel, Erol, and Ramamoorthy, Sonia L. The safety of Liposomal Bupivacaine, a novel local analgesic formation. Clin J Pain, Vol. 30, No. 2, February 2014.